Skip to main content
Home
  • Clinical Outcome Assessments
    Clinical Outcome Assessments

    What are Clinical Outcome Assessments (COAs)? What do they measure?

    Learn more about COAs
    hero_1.jpeg
    The most trusted distributor of COAs

    700+ exclusive COA distributions on behalf of their copyright owners

    hero_2.jpeg
    PROQOLID™: the largest COA database

    7,000+ COAs described in details and accessible in this unique database

  • Services
    Services

    Mapi Research Trust provides turnkey solutions for your Clinical Outcome Assessments (COAs) strategies - including COA databases, targeted literature reviews, licensing.

    Read More
    COA Databases Patient-Centered Endpoint Intelligence COA Licensing Translation and Linguistic Validation eCOA Licensing COA Repository
    hero_3.jpeg
    About ePROVIDE™

    Online access to all our services and COA databases

    hero_2_2.jpeg
    What are eBooklets?

    Find out more about this step-by-step guidance for valid digitization of COAs

  • Author Collaboration
    Author Collaboration

    Our team is dedicated to assisting authors in the daily management of their questionnaires and all derivatives, including translations and electronic versions

    Read More
    COA distribution COA copyright and protection Promotion of COAs and developers Testimonials
    hero_3_1.jpeg
    Catalog of COAs distributed by Mapi Research Trust

    800+ exclusive distributions of COAs, accessible in ePROVIDE

  • Resources
    Resources

    ACCESS all our resources on COAs and eCOA: webinars, publications, blogs. SUBSCRIBE to receive email updates.

    Read More
    Blog Publications Useful links Webinar recordings Whitepapers
    Whitepaper-Digitizing-COAs.jpg
    New whitepaper

    Digitizing COAs: A streamlined approach to approval

    hero_4_2.jpeg
    New whitepaper

    COAs and copyright: How to mitigate risks of infringement and misuse in clinical research and practice

  • News & Events
    News & Events

    Stay informed with our latest news and check all our upcoming events. SUBSCRIBE to get email updates.

    Read More
    hero_5_1.jpeg
    News
    Hero_5_2.jpeg
    Conferences
    Hero_5_3.jpeg
    Webinars
  • About us
    About us

    Mapi Research Trust is a non-profit organization dedicated to improving patients’ quality of life by facilitating access to Clinical Outcome Assessments(COAs).

    Read More
    hero_6_1.jpeg
    Team

    A global team of multi-disciplinary experts

    hero_6_2.jpeg
    Experience

    Collecting & Processing Patient Centered Outcomes information for more than two decades

  • Contact
  1. Home
  2. News & Events
  3. News
  4. Mrs Rosalind Plowright

Mrs Rosalind Plowright

With great sadness I announce that Mrs Rosalind Plowright died on 5th October following diagnosis of cancer earlier this year. Rosalind was an undergraduate student in the psychology department at Royal Holloway from 1990 to 1993, graduating with a first-class degree. I supervised her third-year research project involving evaluation of questionnaires used with patients with diabetes in general practice. Following graduation, she stayed on at Royal Holloway to work as a researcher in the Diabetes Research Group, which later became Health Psychology Research and, in 2010, an independent research unit, the Health Psychology Research Unit (HPRU). Rosalind worked with me for 24 years. She worked with Mapi for almost as long, and very much enjoyed visiting Mapi in Lyon for international harmonisation meetings.
Rosalind was a linguist as well as a research psychologist. She had fluent German, having lived in Germany for a time and taught German for six years: she also had what she herself described as ‘reasonable French, some Spanish, and Italian’. Rosalind had a great facility with languages and interest in how they grow and change when they are exported to other countries: an interest of direct relevance to the linguistic validation of questionnaires. In the early 1990s when she first joined my research group, linguistic validation methodology was in its infancy and Rosalind made important contributions to the development of the gold standard procedures used today. In recent years she managed the linguistic validation team in HPR Ltd, overseeing the work to create new language versions of the 60 or more questionnaires developed by HPRU, some of which are in 110+ languages. When commercial funding was available for the linguistic validation work, Rosalind and her team collaborated frequently with Mapi in Lyon. When external funding was not available, clinicians and academics able to put together the necessary team of linguists, interviewer and clinicians, were supported by Rosalind and her team step by step through the linguistic validation process and quality control, to produce new gold-standard language versions of questionnaires needed. Rosalind provided such support for many clinicians, academics and students globally.
Rosalind had an Honorary Associate Researcher role in HPRU where she was involved in projects designing new questionnaires, ensuring that the English used would be readily translatable into other languages when needed.  She contributed to several publications and conference presentations. Her enthusiasm for her work was infectious and she had been training others in recent years to pass on her skills and expertise in preparation for her retirement. She had planned to retire at the end of 2016 but, sadly, Rosalind’s departure from Royal Holloway was hastened by ill-health.  We will all miss her.
 
Clare Bradley, Professor of Health Psychology, Head of HPRU and CEO of HPR Ltd, Royal Holloway, University of London
21 November 2016

In this section
In this section
  • News
  • Events
    • Conferences
    • Webinars
Site Branding
    ICON plc
  • Contact
  • About Us
For Clients
  • Services
  • Resources
  • ePROVIDE™
News & Events
  • News
  • Conferences
  • Webinars
Socials
  • Linkedin

Legal Footer

  • © 2025 Mapi Research Trust
  • Disclaimer
  • Privacy
  • Site Cookies
How can we help?
  • All
Popular search terms:
  • COVID-19
  • Site & Patient Recruitment
  • Oncology
  • Medical Device
  • Real World Evidence
  • Decentralised & hybrid clinical trials
  • Digital Disruption